LEADER 00925nam2-22002771i-450-
001 990002213390403321
005 20120412111109.0
035   $a000221339
035   $aFED01000221339
035   $a(Aleph)000221339FED01
035   $a000221339
100   $a20030910d1968----km-y0itay50------ba
101 0 $aeng
200 1 $a<<10.: >>Monoamine oxidase inhibitors$erelationship between pharmacological and clinical effects$fedited by J. Cheymol, J. R. Boissier
210   $aOxford$cPergamon press$d1968
215   $avii, 94 p.$cill.$d23 cm
461  0$1001000916474$12001$aProceedings of the third international pharmacological meeting$v10
702  1$aBoissier,$bJacques R.
702  1$aCheymol,$bJean
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990002213390403321
952   $a80 XIV D 26(10)$b1540$fFFABC
959   $aFFABC
996   $aMonoamine oxidase inhibitors$9396396
997   $aUNINA